Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Bruker Reports First Quarter 2025 Financial Results

Q1 2025 revenues of $801.4 million, up 11.0% year-over-year; organic revenue up 2.9%, and constant-exchange rate (CER) revenue up 12.5%; Bruker Scientific Instrument (BSI) segment organic revenue up 5.1% Q1 2025 GAAP diluted EPS $0.11; non-GAAP diluted EPS $0.47, down 11.3% yoy on M&A …

EODHD | 07 May 2025

Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results

Apellis Pharmaceuticals, Inc. Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product sales SYFOVRE® (pegcetacoplan injection) injection demand grew 4% quarter-over-quarter, with U.S. net product revenue of $130.2 million Increase in demand offset by inventory dynamics and funding shortages …

EODHD | 07 May 2025

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance

-- Generated $52.5 million in net revenue from sales of LUMRYZ™, a 93% increase over the first quarter of 2024 -- -- 2,800 patients on LUMRYZ as of March 31, 2025, a net increase of 300 patients since December 31, 2024 and a 100% …

EODHD | 07 May 2025

Bentley Systems Announces First Quarter 2025 Results

EXTON, Pa., May 07, 2025--(BUSINESS WIRE)--Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced results for the quarter ended March 31, 2025. First Quarter 2025 Results Total revenues were $370.5 million, up 9.7% or 10.9% on a constant currency basis, year-over-year; …

EODHD | 07 May 2025

C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Updated Cemsidomide Multiple Myeloma Data Further Demonstrate Compelling Response Rates at Multiple Doses and Potential for Best-in-Class Profile; 50% ORR Observed at the Highest Dose Level of 100 µg, Including One Patient With a Minimal Residual Disease Negative Complete Response; 40% ORR Achieved at …

EODHD | 07 May 2025

CDW Reports First Quarter 2025 Earnings

VERNON HILLS, Ill., May 07, 2025--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW): (Dollars in millions, except per share amounts and percentage) Three Months Ended March 31, 2025 2024 Percent Change Net sales $ 5,199.1 $ 4,872.7 6.7 Gross profit $ 1,122.3 $ 1,063.3 5.5 Gross profit …

EODHD | 07 May 2025

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

–Board Approves Appointment of Four New Directors – –Strategic Planning and Capital Allocation Committee of the Board to Conduct Comprehensive Strategic Review of the Company’s Business – –Enters into Cooperation Agreement with Elliott Investment Management – WILMINGTON, Mass., May 07, 2025--(BUSINESS WIRE)--Charles River Laboratories …

EODHD | 07 May 2025

Delek Logistics Reports Record First Quarter 2025 Results

Net income of $39.0 million Reported Adjusted EBITDA of $116.5 million up 15% year over year On track to deliver $480 million to $520 million in full year Adjusted EBITDA Announced additional intercompany agreements with Delek US increasing the third-party EBITDA contribution to ~80% …

EODHD | 07 May 2025

GDS to Report First Quarter 2025 Financial Results Before the Open of the U.S. Market on May 20, 2025

SHANGHAI, China, May 07, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it will report its first quarter 2025 unaudited financial …

EODHD | 07 May 2025

Cirrus SR Series G7+ unveiled with its Safe Return Emergency Autoland, becoming the first piston-powered aircraft with Garmin Autoland

OLATHE, Kan., May 7, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced its award-winning Autoland system has been certified for the newest SR Series model, the SR Series G7+. The Cirrus Safe Return™ Emergency Autoland system in all new SR20, SR22 and SR22T aircraft …

EODHD | 07 May 2025
Support

Hi! How can we help you today?

Loading…